Mayo Clinic Positions Itself as a National Hub for Testicular Cancer Care
Health

Mayo Clinic Positions Itself as a National Hub for Testicular Cancer Care

Mayo Clinic treats more than 400 testicular cancer patients annually across three U.S. campuses, leveraging multidiscipl...

Noa Feldman 👁 20 💬 0
Pope Leo XIV Has Lung Cancer: What His Adenocarcinoma Diagnosis Means
Health

Pope Leo XIV Has Lung Cancer: What His Adenocarcinoma Diagnosis Means

Pope Leo XIV's 90-minute surgery removed the lower lobe of his right lung and confirmed lung adenocarcinoma, the most co...

Noa Feldman 👁 19 💬 0
FDA Approves Pluvicto for Hormone-Sensitive Metastatic Prostate Cancer
Health

FDA Approves Pluvicto for Hormone-Sensitive Metastatic Prostate Cancer

The targeted radiation drug can now be used with hormone therapy in PSMA-positive metastatic prostate cancer after trial...

Noa Feldman 👁 59 💬 0
Cancer Surgery Wait Times Rose Across Six Tumor Types From 2012 to 2023, Study Finds
Health

Cancer Surgery Wait Times Rose Across Six Tumor Types From 2012 to 2023, Study Finds

A 2.7-million-patient National Cancer Database study found median time from diagnosis to first cancer treatment rose for...

Noa Feldman 👁 48 💬 0
Ipsen’s Cabozantinib Offers New Option for Advanced Neuroendocrine Tumours After EU Approval
Health

Ipsen’s Cabozantinib Offers New Option for Advanced Neuroendocrine Tumours After EU Approval

The targeted therapy, which blocks tumour growth, showed a 77% reduction in progression risk for pancreatic neuroendocri...

Noa Feldman 👁 39 💬 0
AstraZeneca and Bristol Myers in Talks Over Potential $400 Billion Pharma Merger
Companies

AstraZeneca and Bristol Myers in Talks Over Potential $400 Billion Pharma Merger

Report says the two drugmakers discussed a merger that would create a $400 billion oncology powerhouse, but the talks co...

Declan Byrne 👁 49 💬 0
AstraZeneca and Bristol Myers Squibb in Talks Over $400bn Pharma Merger
Companies

AstraZeneca and Bristol Myers Squibb in Talks Over $400bn Pharma Merger

AstraZeneca and Bristol Myers Squibb are in merger talks that could create a nearly $400bn pharmaceutical giant, the Fin...

Declan Byrne 👁 55 💬 0
Early-Stage KRAS Vaccine Trial Signals Potential for Pancreatic Cancer Prevention
Health

Early-Stage KRAS Vaccine Trial Signals Potential for Pancreatic Cancer Prevention

A small trial of a KRAS-targeting vaccine in people at high risk of pancreatic cancer found it safe and able to spark a ...

Noa Feldman 👁 42 💬 0